# Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data

> **NCT04985448** · — · UNKNOWN · sponsor: **Chengdu Kanghong Biotech Co., Ltd.** · enrollment: 1000 (estimated)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04985448
- **Lead sponsor:** Chengdu Kanghong Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04985448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04985448, "Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04985448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*